Daily Program| SBiS 2020 : A Decade of Building a Global Korean Vascular Network | ||
| 쉐라톤 서울 팔래스 강남 호텔 다이너스티홀 | ||
| 08:30-08:50 |
Registration
사회: 박형섭 (서울의대)
|
|
| 08:50-08:55 |
Opening Address
Ku Yong Chung (Ewha Womans Univ.)
정구용 (이화의대)
|
|
| 08:55-09:00 |
Course review
Taeseung Lee (Seoul National Univ.)
이태승 (서울의대)
|
|
| Session 1. LIVE connection with USA (I) | ||
| 09:00-10:30 |
Moderators:
Taeseung Lee (Seoul National Univ.)
이태승 (서울의대)
Hyung Sub Park (Seoul National Univ.)
박형섭 (서울의대)
|
|
| 09:00-09:15 |
Recorded live case 1: Transcarotid Arterial Revascularization (TCAR)
Jae Sung Cho (Case Western Reserve Univ., USA)
 |
|
| 09:15-09:30 |
Recorded live case 2: In-Situ FEVAR for ruptured unstable TAAA
Sukgu Han (Univ. of Southern California, USA)
|
|
| 09:30-09:45 |
Vascular surgeon's role during the COVID-19 pandemic: experience in the heart of NY
Daniel K. Han (Mount Sinai Univ., USA)
|
|
| 09:45-10:00 |
Perioperative thromboprophylaxis in COVID-19 patients
Cheong Jun Lee (Northshore Univ., USA)
|
|
| 10:00-10:15 |
BMT vs CEA vs CAS in asymptomatic carotid disease patients
Jae Sung Cho (Case Western Reserve Univ., USA)
|
|
| 10:15-10:30 |
Customized FEVAR/BEVAR vs PMEG
William J Yoon (Case Western Reserve Univ., USA)
|
|
| 10:30-10:50 |
Coffee break
|
|
| Session 2. LIVE connection with USA (II) | ||
| 10:50-12:20 |
Moderators:
Seung-Kee Min (Seoul National Univ.)
민승기 (서울의대)
Sangil Min (Seoul National Univ.)
민상일 (서울의대)
|
|
| 10:50-11:05 |
Bridging covered stents during FEVAR/BEVAR: which is best and why?
William J Yoon (Case Western Reserve Univ., USA)
|
|
| 11:05-11:20 |
Neoaortoiliac System (NAIS) Procedure for Infected Aortic Graft Treatment
Jayer Chung (Baylor Univ., USA)
|
|
| 11:20-11:35 |
DCB/DES use in claudicants vs critical limb ischemia patients: should they differ?
Cheong Jun Lee (Northshore Univ., USA)
|
|
| 11:35-11:50 |
Guideline-based role of surgery in PAD: Will the BASIL-2 and BEST-CLI trials be a game changer?
Jayer Chung (Baylor Univ., USA)
|
|
| 11:50-12:20 |
Debate: The current status of the endovascular drive in thoracoabdominal aorta pathology
|
|
|
1. Deviating from the endo track (back to open)
Suk-Won Song (Ewha Womans Univ.)
송석원 (이화의대)
|
||
|
2. Still in track with some minor bumps (endo favored)
Sukgu Han (Univ. of Southern California, USA)
|
||
| Special Session. LUNCHEON (Sponsored by BD Bard) | ||
| 12:30-13:30 |
Moderators:
Jongwon Ha (Seoul National Univ.)
하종원 (서울의대)
|
|
| 12:30-13:30 |
Recorded lecture: Optimize Venous Stenting Outcomes : 24 month Vernacular Trial Results & Lessons Learned from the Expert on Venous Stenting
Paul Gagne (Norwalk Hospital)
|
|
| Session 3. Deep venous intervention: In Depth | ||
| 13:30-14:50 |
Moderators:
In Mok Jung (Seoul National Univ.)
정인목 (서울의대)
Sang Woo Park (Konkuk Univ.)
박상우 (건국의대)
|
|
| 13:30-13:40 |
Recorded live case 3: PMEG for TAAA
|
|
| 13:40-13:50 |
Limitations of the CAVENT, ATTRACT and CAVA trials: Is anticoagulation alone enough for acute DVT
Young Sun Yoo (Chosun Univ.)
유영선 (조선의대)
|
|
| 13:50-14:00 |
Advantages of pharmacomechanical thrombectomy for deep vein thrombosis
Sang Woo Park (Konkuk Univ.)
박상우 (건국의대)
|
|
| 14:00-14:10 |
Thrombotic vs nonthrombotic iliocaval obstruction: Management strategies for CVI intervention
Hyung Sub Park (Seoul National Univ.)
박형섭 (서울의대)
|
|
| 14:10-14:20 |
Medical management after deep venous stenting
Keun Myoung Park (Incheon Vascular Surgery)
박근명 (인천외과의원)
|
|
| 14:20-14:30 |
Can all chronically occluded IVC filters be removed? Tips and tricks
Je Hwan Won (Ajou Univ.)
원제환 (아주의대)
|
|
| 14:30-14:50 |
Panel discussion
|
|
| 14:50-15:10 |
Coffee break
|
|
| Session 4. Drug-based technology in PAD: Issues and solutions | ||
| 15:10-16:20 |
Moderators:
Sang Joon Kim (Professor Emeritus, Seoul National Univ.)
김상준 (서울의대)
Hwan Jun Jae (Seoul National Univ.)
제환준 (서울의대)
|
|
| 15:10-15:20 |
One year since the DCB issue: what's the current evidence
Suh Min Kim (Chung-Ang Univ.)
김서민 (중앙의대)
|
|
| 15:20-15:30 |
Pharmacology and toxicity of Paclitaxel: what's the influence?
Seung-Woon Rha (Korea Univ.)
나승운 (고려의대)
|
|
| 15:30-15:40 |
Is the increase in patency of drug-based technology justifiable in terms of cost-effectiveness?
Chang-Hwan Yoon (Seoul National Univ.)
윤창환 (서울의대)
|
|
| 15:40-15:50 |
Updates on drug-based technology for BTK intervention
Jae-Hwan Lee (Chungnam National Univ.)
이재환 (충남의대)
|
|
| 15:50-16:00 |
Strategies to improve drug-delivery efficiency in the SFA: are we dealing aggressively enough with the calcium burden?
Jang Yong Kim (Catholic Univ.)
김장용 (가톨릭의대)
|
|
| 16:00-16:20 |
Panel discussion
|
|
| Session 5. The Aorta Essentials | ||
| 16:20-18:00 |
Moderators:
Youngwook Kim (Incheon Sejong Hosp.)
김영욱 (인천세종병원)
Yong-Pil Cho (Ulsan Univ.)
조용필 (울산의대)
|
|
| 16:20-16:30 |
Recorded live case 4: Late open conversion after EVAR
|
|
| 16:30-17:00 |
Debate: Lowering the diameter threshold of EVAR to less than 5.5 cm
|
|
|
1. Yes, an overstreched spring never comes back
Kwang-Hun Lee (Ewha Womans Univ.)
이광훈 (이화의대)
|
||
|
2. No, that is not evidence-based or cost-effective
Sang Su Lee (Pusan National Univ.)
이상수 (부산의대)
|
||
| 17:00-17:10 |
Updates in medical treatment of AAA: the same old guys or any new kids on the stage?
Jin Mo Kang (Gachon Univ.)
강진모 (가천의대)
|
|
| 17:10-17:20 |
Implications of the NICE guideline: should all elective AAAs be treated surgically?
Seung-Kee Min (Seoul National Univ.)
민승기 (서울의대)
|
|
| 17:20-17:30 |
Unveiling sac biology: Rapid sac growth phenomenon after EVAR compared to untreated natural AAA - What's the implication?
Jin Hyun Joh (Kyung Hee Univ.)
조진현 (경희의대)
|
|
| 17:30-17:40 |
Late ruptures of AAA after EVAR
Seung Huh (Kyungpook National Univ.)
허승 (경북의대)
|
|
| 17:40-17:50 |
EVAR for ruptured AAA: ways to increase implementation.
Sun Cheol Park (Catholic Univ.)
박순철 (가톨릭의대)
|
|
| 17:50-18:00 |
Panel discussion
|
|
| 18:00-00:00 |
Closing Remarks
|
|
